SMAD3 Human shRNA Lentiviral Particle (Locus ID 4088)

CAT#: TL309254V

SMAD3 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Product Images

GFP signal was observed under microscope at 48 hours after transduction of TL309254A virus into HEK293 cells. TL309254A virus was prepared using lenti-shRNA TL309254A and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of TL309254B virus into HEK293 cells. TL309254B virus was prepared using lenti-shRNA TL309254B and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL309254C] virus into HEK293 cells. [TL309254C] virus was prepared using lenti-shRNA [TL309254C] and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL309254D] virus into HEK293 cells. [TL309254D] virus was prepared using lenti-shRNA [TL309254D] and TR30037 packaging kit.

Specifications

Product Data

• Locus ID: 4088
• Synonyms: HSPC193; HsT17436; JV15-2; LDS1C; LDS3; MADH3
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: NM_001145102, NM_001145103, NM_001145104, NM_005902, NM_005902.1, NM_005902.2, NM_005902.3, NM_001145102.1, NM_001145103.1, NM_001145104.1, BC050743, BC050743.1, BC000414, BC007496, BM551682, BM722372
• UniProt ID: P84022
• Summary: The SMAD family of proteins are a group of intracellular signal transducer proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. The SMAD3 protein functions in the transforming growth factor-beta signaling pathway, and transmits signals from the cell surface to the nucleus, regulating gene activity and cell proliferation. It also functions as a tumor suppressor. Mutations in this gene are associated with aneurysms-osteoarthritis syndrome and Loeys-Dietz Syndrome 3. [provided by RefSeq, Nov 2019]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).